Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine

This study investigated the immune response and outcome of BNT162b2 vaccination among 12 staff at a hospital in Fukushima, Japan. Blood samples were collected from participants before their first vaccination, with subsequent sampling performed during the participants’ work days for six weeks thereaf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobashi, Yurie, Shimazu, Yuzo, Kawamura, Takeshi, Nishikawa, Yoshitaka, Omata, Fumiya, Kaneko, Yudai, Kodama, Tatsuhiko, Tsubokura, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Fukushima Society of Medical Science 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071351/
https://www.ncbi.nlm.nih.gov/pubmed/35228456
http://dx.doi.org/10.5387/fms.2021-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071351/
https://www.ncbi.nlm.nih.gov/pubmed/35228456
http://dx.doi.org/10.5387/fms.2021-28

Ejemplares similares